Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Seminoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Medulloblastoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hearing Loss 1Carcinoma 1

Interventions

Cyclophosphamide 6Temozolomide 5Etoposide 5Vincristine 3Radiotherapy 3Cisplatin 3lutetium Lu 177 dotatate 2etoposide phosphate 2Radiation 2Filgrastim 2Celecoxib 2Carboplatin 2sodium thiosulfate 1ribociclib 1pegfilgrastim 1palbociclib 1olaparib 1ibrutinib 1fludarabine 1fenofibric acid 1abemaciclib 1Topotecan 1Thiotepa 1Thalidomide 1Tamoxifen 1Tablets 1Standard of Care 1Specimen Handling 1Platinum 1ONC206 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Medulloblastoma × Hearing × Clear all
NCT05382338 2026-05-05

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Children's Oncology Group

Phase 3 Recruiting
225 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡